In contrast, India's Indian Council of Medical Research (ICMR) has recommends its use for COVID-19 treatment, maintaining that it has no major side-effects. These antibiotics are either treated in the hospital or in some instances, there are some who self-medicate.
Director-General Tedros Adhanom Ghebreyesus stated data provided by some countries indicated that the number of bacterial infectious was well concerned, which has become increasingly resistant to the medicines traditionally used to treat them. World Health Organization refers to the antibiotics that are traditionally used to treat diseases.
The global health body warned that the inappropriate and indiscriminate use of antibiotics during the COVID-19 could cause more problems than what it is supposed to solve.
Johanna Swanson, product manager at GlobalData, said: "Severe COVID-19 patients may develop acute respiratory distress syndrome (ARDS) due to the cytokine storm, which can lead to long-term lung damage and fibrosis".
"Evidence shows that only small proportion of COVID-19 patients need antibiotics to treat subsequent bacterial infections and the organization has issued guidance not to provide antibiotic therapy or prophylaxis to patients with mild COVID-19 or to patients with suspected or confirmed moderate COVID-19 illness unless there is a clinical indication to do so, "it said".
'The threat of antimicrobial resistance is one of the most urgent challenges of our time'.
"It's clear that the world is losing its ability to use critically important antimicrobial medicines", he said. Pres. Donald Trump even admitted that he was taking the anti-malarial drug for almost two weeks but eventually stop using it.
The most common reasons for discontinuing or reducing services were cancellations of planned treatments, a decrease in available public transport and a lack of staff because health workers had been reassigned to COVID-19 treatment.
Some studies had suggested that people who were taking the drug for COVID-19 had a higher chance of dying than those who were not.
The survey also found that 42% of countries had interrupted services for cancer patients and 31% for heart emergencies.
WHO Director-General Tedros also said: "The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board".
Global smartphone sales declined 20% in Q1 2020: Gartner
Apple had a solid beginning to the year many thanks to its brand-new line of product up that saw solid energy internationally. Even with its first ever decline in smartphone sales, Huawei held on to the No. 2 position with 14.2% market share .